BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26573557)

  • 21. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.
    Marzaioli V; McMorrow JP; Angerer H; Gilmore A; Crean D; Zocco D; Rooney P; Veale D; Fearon U; Gogarty M; McEvoy AN; Stradner MH; Murphy EP
    Arthritis Rheum; 2012 Oct; 64(10):3290-301. PubMed ID: 22674155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Osteoprotegerin and receptor activator of nuclear factor kappa B ligand mRNAs expression in BMSCs of glucocorticoid-induced necrosis of the femoral head patients].
    Wang J; Gao H; Wang K; Li W; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jul; 23(7):777-80. PubMed ID: 19662974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
    Wang J; Wang K; Shi Z; Zhang M
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Teriparatide ameliorates articular cartilage degradation and aberrant subchondral bone remodeling in DMM mice.
    Li G; Liu S; Chen Y; Xu H; Qi T; Xiong A; Wang D; Yu F; Weng J; Zeng H
    J Orthop Translat; 2023 Jan; 38():241-255. PubMed ID: 36514714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles.
    Liu YD; Yang HX; Liao LF; Jiao K; Zhang HY; Lu L; Zhang M; Zhang J; He JJ; Wu YP; Chen D; Wang MQ
    Osteoarthritis Cartilage; 2016 Jan; 24(1):178-187. PubMed ID: 26256766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats].
    Wang JZ; Gao HY; Wang KZ; Zhou RX; Li XD; Guo J; Lv HC
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1714-7. PubMed ID: 22027774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular mechanism of bone remodelling during mandibular distraction osteogenesis in rats].
    Zhu WQ; Wang X; Wang XX; Wang ZY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Dec; 42(12):729-32. PubMed ID: 18476557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of RANKL/OPG during bone remodeling in vivo.
    Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT
    Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study.
    Tat SK; Pelletier JP; Vergés J; Lajeunesse D; Montell E; Fahmi H; Lavigne M; Martel-Pelletier J
    Arthritis Res Ther; 2007; 9(6):R117. PubMed ID: 17996099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of relaxin and estrogens on bone remodeling markers, receptor activator of NF-kB ligand (RANKL) and osteoprotegerin (OPG), in rat adjuvant-induced arthritis.
    Ho TY; Santora K; Chen JC; Frankshun AL; Bagnell CA
    Bone; 2011 Jun; 48(6):1346-53. PubMed ID: 21419242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
    Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
    Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of receptor activator of nuclear factor kappaB ligand, receptor activator of nuclear factor kappaB, and osteoprotegerin messenger RNA in aged and ovariectomized rat bones.
    Ikeda T; Utsuyama M; Hirokawa K
    J Bone Miner Res; 2001 Aug; 16(8):1416-25. PubMed ID: 11499864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulatory Effects and Interactions of the Wnt and OPG-RANKL-RANK Signaling at the Bone-Cartilage Interface in Osteoarthritis.
    Kovács B; Vajda E; Nagy EE
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review).
    Liu W; Zhang X
    Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.
    Schubert A; Schulz H; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jun; 24(6):331-8. PubMed ID: 18584413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Wenhua Juanbi Recipe () on expression of receptor activator of nuclear factor kappa B ligand, osteoprotegerin, and tumor necrosis factor receptor superfamily member 14 in rats with collagen-induced arthritis.
    Liu XD; Wang YQ; Cai L; Ye LH; Wang F; Feng YY
    Chin J Integr Med; 2017 Mar; 23(3):208-214. PubMed ID: 28004300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males.
    Findlay D; Chehade M; Tsangari H; Neale S; Hay S; Hopwood B; Pannach S; O'Loughlin P; Fazzalari N
    Arthritis Res Ther; 2008; 10(1):R2. PubMed ID: 18182105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.
    Melchiorre D; Milia AF; Linari S; Romano E; Benelli G; Manetti M; Guiducci S; Ceccarelli C; Innocenti M; Carulli C; Civinini R; Morfini M; Matucci-Cerinic M; Ibba-Manneschi L
    J Rheumatol; 2012 Aug; 39(8):1678-86. PubMed ID: 22753650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of modified sijunzi decoction on the bone metabolism of adriamycin induced nephropathy rats].
    Zheng J; Liu JL; Lin MF; Wang ZF; Liu CY; Wu XH; Lin HY; Chen CF; Zheng XM; Chen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1376-81. PubMed ID: 24432683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.